<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="985">
  <stage>Registered</stage>
  <submitdate>9/01/2006</submitdate>
  <approvaldate>9/01/2006</approvaldate>
  <actrnumber>ACTRN12606000014550</actrnumber>
  <trial_identification>
    <studytitle>A novel sensory nerve stimulator to improve neuropathy in patients with diabetes</studytitle>
    <scientifictitle>The use of low frequency transcutaneous sensory nerve stimulation to improve sensory nerve function and symptoms in people with diabetic peripheral neuropathy</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Diabetic peripheral neuropathy</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Double blind placebo randomised controlled trial of low frequency sensory electrical nerve stimulation within two different population groups over 12 weeks of treatment.</interventions>
    <comparator>Placebo</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Comparison of the effect of treatment on vascular measures</outcome>
      <timepoint>From baseline to 12 weeks post treatment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Comparison of the effect of treatment on neuronal measures</outcome>
      <timepoint>From baseline to 12 weeks post treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Comparison of the effect of treatment on subjective sensory measures.</outcome>
      <timepoint>From baseline to 12 weeks post treatment.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Group 1: Persons aged 55 to 65, with known diabetes duration of up to 5 years.Group 2: Persons aged 55 to 75, with known diabetes duration of up to 10 years.DPN diagnosed as insensate to 10g monofilament or reduced vibration below 4octals 128Hz graduated tuning fork. </inclusivecriteria>
    <inclusiveminage>55</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inability to consent to the research, an above or below-knee amputation, cigarette smoking.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation is concealed for the duration of the trial in sealed envelopes</concealment>
    <sequence>Block randomisation to ensure randomisation of placebo and active is even regardless of sample size, with the random allocation sequence formulated by using a random number table in excel</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>20/02/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>220</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>A/Prof Zeinab Khalil</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NH&amp;MRC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Melbourne, Department of Biochemistry and Molecular Biology</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Melbourne Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Rajna Ogrin</name>
      <address>Department of Biochemistry and Molecular Biology
University of Melbourne
Parkville VIC 3010</address>
      <phone>+61 3 83445919</phone>
      <fax>+61 3 93482251</fax>
      <email>rajna.ogrin@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Rajna Ogrin</name>
      <address>Department of Biochemistry and Molecular Biology
University of Melbourne
Parkville VIC 3010</address>
      <phone>+61 3 83445919</phone>
      <fax>+61 3 93482251</fax>
      <email>rajna.ogrin@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>